Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A study to look at the long-term safety of a medicine, efmarodocokin alfa, in people with ulcerative colitis
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
Autoimmune Disorder Crohn's Disease Inflammatory Bowel Disease (IBD) Ulcerative Colitis
- Results
-
Download -
Study results
LPS GA40209 SERENGETI Final Results April 2023 Bulgaria Bulgarian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 English
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Georgia Georgian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Germany German
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Greece Greek
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Italy Italian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Moldova Romanian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Poland Polish
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Russia Russian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Serbia Serbian
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Spanish Spain
(PDF, 0.2 MB)
LPS GA40209 SERENGETI Final Results April 2023 Spanish USA
(PDF, 0.1 MB)
LPS GA40209 SERENGETI Final Results April 2023 Ukraine Ukrainian
(PDF, 0.2 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com